scispace - formally typeset
C

Celia Badenas

Researcher at University of Barcelona

Publications -  44
Citations -  1955

Celia Badenas is an academic researcher from University of Barcelona. The author has contributed to research in topics: Porphyria & Germline mutation. The author has an hindex of 15, co-authored 44 publications receiving 1740 citations. Previous affiliations of Celia Badenas include Carlos III Health Institute.

Papers
More filters
Journal ArticleDOI

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Corine Bertolotto, +98 more
- 01 Dec 2011 - 
TL;DR: A germline missense substitution in MITF (Mi-E318K) is identified that occurred at a significantly higher frequency in genetically enriched patients affected with melanoma, RCC or both cancers, when compared with controls and provides insights into the link between SUMOylation, transcription and cancer.
Journal ArticleDOI

High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

Alisa M. Goldstein, +99 more
- 15 Oct 2006 - 
TL;DR: This GenoMEL study provides the most extensive characterization of mutations in high-risk melanoma susceptibility genes in families with three or more melanoma patients yet available and there was little evidence for an association between CDKN2A mutations and NST, but there was a marginally significant association between NST and ARF.
Journal ArticleDOI

Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families.

TL;DR: In this article, the authors evaluated 398 fragile X syndrome (FXS) families in an attempt to provide an estimation of the premutation associated phenotypes penetrance, and the results showed that signs of FXTAS are detected in 16.5% of female premutation carriers and in 45% of premutated males older than 50 years.
Journal ArticleDOI

A melanoma-associated germline mutation in exon 1β inactivates p14ARF

TL;DR: A 16 base pair exon 1β germline insertion specifically altering p14ARF, but not p16INK4a, in an individual with multiple primary melanomas implicates a role for this tumour suppressor in melanoma predisposition.